Do analysts recommend SYRA or SJ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Scienjoy 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SYRA or SJ more profitable?

Scienjoy has a net margin of -46.33% compared to Syra Health's net margin of -54.90%. Scienjoy's return on equity of -63.91% beat Syra Health's return on equity. Company Net Margins Return on Equity Return on Assets Syra Health -54.90% -131.94% -99.19% Scienjoy -46.33% -63.91% -54.20%

Do analysts rate KPLT or SYRA?

Katapult currently has a consensus target price of $10.00, suggesting a potential upside of 29.20%. Given Katapult's stronger consensus rating and higher probable upside, analysts clearly believe Katapult is more favorable than Syra Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Katapult 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings and valuation, KPLT or SYRA?

Katapult has higher revenue and earnings than Syra Health. Syra Health is trading at a lower price-to-earnings ratio than Katapult, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Katapult $291.76M 0.13 $1.37M $1.15 6.73 Syra Health $7.98M 1.18 -$2.94M -$0.02 N/A

Is KPLT or SYRA more profitable?

Katapult has a net margin of 2.48% compared to Syra Health's net margin of -54.90%. Katapult's return on equity of -16.24% beat Syra Health's return on equity. Company Net Margins Return on Equity Return on Assets Katapult 2.48% -16.24% 7.63% Syra Health -54.90% -131.94% -99.19%

Do analysts prefer DGNX or SYRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Diginex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, DGNX or SYRA?

Syra Health has higher revenue and earnings than Diginex. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Diginex $2.04M 13.98 -$5.21M N/A N/A Syra Health $7.98M 1.18 -$2.94M -$0.02 N/A

Is DGNX or SYRA more profitable?

Diginex has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Diginex's return on equity of 0.00% beat Syra Health's return on equity. Company Net Margins Return on Equity Return on Assets Diginex N/A N/A N/A Syra Health -54.90% -131.94% -99.19%

Does the media favor DGNX or SYRA?

In the previous week, Diginex had 1 more articles in the media than Syra Health. MarketBeat recorded 2 mentions for Diginex and 1 mentions for Syra Health. Diginex's average media sentiment score of 0.30 beat Syra Health's score of 0.00 indicating that Diginex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Diginex 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Syra Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate SYRA or XBP?

XBP Global has a consensus target price of $5.00, suggesting a potential upside of 104.08%. Given XBP Global's stronger consensus rating and higher possible upside, analysts plainly believe XBP Global is more favorable than Syra Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 XBP Global 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings & valuation, SYRA or XBP?

XBP Global has higher revenue and earnings than Syra Health. Syra Health is trading at a lower price-to-earnings ratio than XBP Global, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Syra Health $7.98M 1.18 -$2.94M -$0.02 N/A XBP Global $791.04M 0.04 $1.10B -$3.28 N/A

Is SYRA or XBP more profitable?

XBP Global has a net margin of 130.26% compared to Syra Health's net margin of -54.90%. XBP Global's return on equity of 1,645.47% beat Syra Health's return on equity. Company Net Margins Return on Equity Return on Assets Syra Health -54.90% -131.94% -99.19% XBP Global 130.26% 1,645.47% 146.77%

Do analysts recommend SYRA or GRNQ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syra Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Greenpro Capital 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor SYRA or GRNQ?

In the previous week, Greenpro Capital had 3 more articles in the media than Syra Health. MarketBeat recorded 4 mentions for Greenpro Capital and 1 mentions for Syra Health. Greenpro Capital's average media sentiment score of 1.30 beat Syra Health's score of 0.00 indicating that Greenpro Capital is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Syra Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Greenpro Capital 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Syra Health (SYRA) Competitors

$0.68 +0.00 (+0.12%)

As of 07/6/2026 03:55 PM Eastern

Compare

SYRA vs. SJ, KPLT, DGNX, XBP, and GRNQ

Should you buy Syra Health stock or one of its competitors? MarketBeat compares Syra Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Syra Health include Scienjoy (SJ), Katapult (KPLT), Diginex (DGNX), XBP Global (XBP), and Greenpro Capital (GRNQ). These companies are all part of the "business services" industry.

How does Syra Health compare to Scienjoy?

Syra Health (NASDAQ:SYRA) and Scienjoy (NASDAQ:SJ) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Scienjoy	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Syra Health had 1 more articles in the media than Scienjoy. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for Scienjoy. Syra Health's average media sentiment score of 0.00 equaled Scienjoy'saverage media sentiment score.

Company	Overall Sentiment
Syra Health	Neutral
Scienjoy	Neutral

Scienjoy has a net margin of -46.33% compared to Syra Health's net margin of -54.90%. Scienjoy's return on equity of -63.91% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syra Health	-54.90%	-131.94%	-99.19%
Scienjoy	-46.33%	-63.91%	-54.20%

Syra Health has a beta of 2.94, meaning that its stock price is 194% more volatile than the broader market. Comparatively, Scienjoy has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

Syra Health has higher earnings, but lower revenue than Scienjoy. Syra Health is trading at a lower price-to-earnings ratio than Scienjoy, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syra Health	$7.98M	1.18	-$2.94M	-$0.02	N/A
Scienjoy	$177.55M	0.22	-$83.95M	-$1.95	N/A

4.8% of Syra Health shares are held by institutional investors. Comparatively, 0.3% of Scienjoy shares are held by institutional investors. 36.5% of Syra Health shares are held by insiders. Comparatively, 33.6% of Scienjoy shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Syra Health beats Scienjoy on 7 of the 13 factors compared between the two stocks.

How does Syra Health compare to Katapult?

Katapult (NASDAQ:KPLT) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

Katapult has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market. Comparatively, Syra Health has a beta of 2.94, suggesting that its stock price is 194% more volatile than the broader market.

In the previous week, Syra Health had 1 more articles in the media than Katapult. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for Katapult. Katapult's average media sentiment score of 0.00 equaled Syra Health'saverage media sentiment score.

Company	Overall Sentiment
Katapult	Neutral
Syra Health	Neutral

Katapult has a net margin of 2.48% compared to Syra Health's net margin of -54.90%. Katapult's return on equity of -16.24% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Katapult	2.48%	-16.24%	7.63%
Syra Health	-54.90%	-131.94%	-99.19%

Katapult has higher revenue and earnings than Syra Health. Syra Health is trading at a lower price-to-earnings ratio than Katapult, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Katapult	$291.76M	0.13	$1.37M	$1.15	6.73
Syra Health	$7.98M	1.18	-$2.94M	-$0.02	N/A

Katapult currently has a consensus target price of $10.00, suggesting a potential upside of 29.20%. Given Katapult's stronger consensus rating and higher probable upside, analysts clearly believe Katapult is more favorable than Syra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Katapult	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

26.8% of Katapult shares are owned by institutional investors. Comparatively, 4.8% of Syra Health shares are owned by institutional investors. 8.0% of Katapult shares are owned by company insiders. Comparatively, 36.5% of Syra Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Katapult beats Syra Health on 10 of the 14 factors compared between the two stocks.

How does Syra Health compare to Diginex?

Diginex (NASDAQ:DGNX) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

Diginex has a beta of -2.73, suggesting that its stock price is 373% less volatile than the broader market. Comparatively, Syra Health has a beta of 2.94, suggesting that its stock price is 194% more volatile than the broader market.

Syra Health has higher revenue and earnings than Diginex.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Diginex	$2.04M	13.98	-$5.21M	N/A	N/A
Syra Health	$7.98M	1.18	-$2.94M	-$0.02	N/A

4.8% of Syra Health shares are held by institutional investors. 36.5% of Syra Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Diginex had 1 more articles in the media than Syra Health. MarketBeat recorded 2 mentions for Diginex and 1 mentions for Syra Health. Diginex's average media sentiment score of 0.30 beat Syra Health's score of 0.00 indicating that Diginex is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Diginex	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Syra Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Diginex has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Diginex's return on equity of 0.00% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Diginex	N/A	N/A	N/A
Syra Health	-54.90%	-131.94%	-99.19%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Diginex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Diginex beats Syra Health on 7 of the 12 factors compared between the two stocks.

How does Syra Health compare to XBP Global?

Syra Health (NASDAQ:SYRA) and XBP Global (NASDAQ:XBP) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends.

4.8% of Syra Health shares are owned by institutional investors. Comparatively, 15.7% of XBP Global shares are owned by institutional investors. 36.5% of Syra Health shares are owned by company insiders. Comparatively, 31.4% of XBP Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

XBP Global has a consensus target price of $5.00, suggesting a potential upside of 104.08%. Given XBP Global's stronger consensus rating and higher possible upside, analysts plainly believe XBP Global is more favorable than Syra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
XBP Global	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Syra Health has a beta of 2.94, indicating that its stock price is 194% more volatile than the broader market. Comparatively, XBP Global has a beta of -0.43, indicating that its stock price is 143% less volatile than the broader market.

In the previous week, Syra Health had 1 more articles in the media than XBP Global. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for XBP Global. Syra Health's average media sentiment score of 0.00 equaled XBP Global'saverage media sentiment score.

Company	Overall Sentiment
Syra Health	Neutral
XBP Global	Neutral

XBP Global has higher revenue and earnings than Syra Health. Syra Health is trading at a lower price-to-earnings ratio than XBP Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syra Health	$7.98M	1.18	-$2.94M	-$0.02	N/A
XBP Global	$791.04M	0.04	$1.10B	-$3.28	N/A

XBP Global has a net margin of 130.26% compared to Syra Health's net margin of -54.90%. XBP Global's return on equity of 1,645.47% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syra Health	-54.90%	-131.94%	-99.19%
XBP Global	130.26%	1,645.47%	146.77%

Summary

XBP Global beats Syra Health on 9 of the 14 factors compared between the two stocks.

How does Syra Health compare to Greenpro Capital?

Syra Health (NASDAQ:SYRA) and Greenpro Capital (NASDAQ:GRNQ) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Syra Health has a net margin of -54.90% compared to Greenpro Capital's net margin of -153.32%. Greenpro Capital's return on equity of -31.13% beat Syra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syra Health	-54.90%	-131.94%	-99.19%
Greenpro Capital	-153.32%	-31.13%	-25.47%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Greenpro Capital	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Syra Health has higher revenue and earnings than Greenpro Capital. Syra Health is trading at a lower price-to-earnings ratio than Greenpro Capital, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syra Health	$7.98M	1.18	-$2.94M	-$0.02	N/A
Greenpro Capital	$2.07M	12.46	-$2.98M	-$0.39	N/A

4.8% of Syra Health shares are held by institutional investors. Comparatively, 0.9% of Greenpro Capital shares are held by institutional investors. 36.5% of Syra Health shares are held by insiders. Comparatively, 39.7% of Greenpro Capital shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Syra Health has a beta of 2.94, meaning that its share price is 194% more volatile than the broader market. Comparatively, Greenpro Capital has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market.

In the previous week, Greenpro Capital had 3 more articles in the media than Syra Health. MarketBeat recorded 4 mentions for Greenpro Capital and 1 mentions for Syra Health. Greenpro Capital's average media sentiment score of 1.30 beat Syra Health's score of 0.00 indicating that Greenpro Capital is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Syra Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Greenpro Capital	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Syra Health and Greenpro Capital tied by winning 7 of the 14 factors compared between the two stocks.

Get Syra Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SYRA vs. The Competition

Export

Metric	Syra Health	Employment agencies Industry	Medical Sector	NASDAQ Exchange
Market Cap	$9.44M	$16.53M	$6.92B	$12.59B
Dividend Yield	N/A	N/A	2.66%	6.52%
P/E Ratio	-1.05	N/A	27.35	24.81
Price / Sales	1.18	0.73	507.73	89.92
Price / Cash	N/A	N/A	29.65	49.23
Price / Book	1.10	0.69	11.06	6.50
Net Income	-$2.94M	-$13.52M	$3.57B	$336.03M
7 Day Performance	6.98%	31.26%	2.56%	2.68%
1 Month Performance	34.12%	14.00%	7.39%	5.50%
1 Year Performance	N/A	10.26%	34.13%	25.01%

Syra Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SYRA Syra Health	N/A	$0.68 +0.1%	N/A	+612.6%	$9.44M	$7.98M	N/A	78	Gap Up
SJ Scienjoy	0.5336 of 5 stars	$0.87 -3.1%	N/A	+11.8%	$35.38M	$1.22B	N/A	280	Gap Up
KPLT Katapult	1.7228 of 5 stars	$7.61 +4.2%	$10.00 +31.4%	-1.5%	$34.78M	$291.76M	6.62	130
DGNX Diginex	0.739 of 5 stars	$1.15 -10.2%	N/A	-97.8%	$32.31M	$3.57M	N/A	21	News Coverage Gap Down
XBP XBP Global	3.6644 of 5 stars	$2.38 -2.9%	$5.00 +110.1%	-73.7%	$28.83M	$791.04M	N/A	10,600	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SYRA) was last updated on 7/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Syra Health (SYRA) Competitors

SYRA vs. SJ, KPLT, DGNX, XBP, and GRNQ

How does Syra Health compare to Scienjoy?

Summary

How does Syra Health compare to Katapult?

Summary

How does Syra Health compare to Diginex?

Summary

How does Syra Health compare to XBP Global?

Summary

How does Syra Health compare to Greenpro Capital?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SYRA vs. The Competition

Syra Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Syra Health (SYRA) Competitors

SYRA vs. SJ, KPLT, DGNX, XBP, and GRNQ

How does Syra Health compare to Scienjoy?

Do analysts recommend SYRA or SJ?

Does the media refer more to SYRA or SJ?

Is SYRA or SJ more profitable?

Which has more volatility & risk, SYRA or SJ?

Which has preferable earnings and valuation, SYRA or SJ?

Do insiders & institutionals hold more shares of SYRA or SJ?

Summary

How does Syra Health compare to Katapult?

Which has more risk and volatility, KPLT or SYRA?

Does the media prefer KPLT or SYRA?

Is KPLT or SYRA more profitable?

Which has higher earnings and valuation, KPLT or SYRA?

Do analysts rate KPLT or SYRA?

Do institutionals & insiders hold more shares of KPLT or SYRA?

Summary

How does Syra Health compare to Diginex?

Which has more volatility & risk, DGNX or SYRA?

Which has stronger earnings and valuation, DGNX or SYRA?

Do insiders & institutionals hold more shares of DGNX or SYRA?

Does the media favor DGNX or SYRA?

Is DGNX or SYRA more profitable?

Do analysts prefer DGNX or SYRA?

Summary

How does Syra Health compare to XBP Global?

Do insiders and institutionals have more ownership in SYRA or XBP?

Do analysts rate SYRA or XBP?

Which has more volatility & risk, SYRA or XBP?

Does the media refer more to SYRA or XBP?

Which has higher earnings & valuation, SYRA or XBP?

Is SYRA or XBP more profitable?

Summary

How does Syra Health compare to Greenpro Capital?

Is SYRA or GRNQ more profitable?

Do analysts recommend SYRA or GRNQ?

Which has preferable earnings and valuation, SYRA or GRNQ?

Do insiders and institutionals have more ownership in SYRA or GRNQ?

Which has more risk & volatility, SYRA or GRNQ?

Does the media favor SYRA or GRNQ?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SYRA vs. The Competition

Syra Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools